Lord, Abbett & Co’s Alamar Biosciences ALMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.5M Buy
425,042
+247,490
+139% +$7.29M 0.04% 336
2026
Q2
$4.81M Buy
+177,552
New +$4.02M 0.01% 483

Other funds holding ALMR

Lord, Abbett & Co's ALMR Position: Q3 2026 in Review

Lord, Abbett & Co increased its Alamar Biosciences (ALMR) stake by 139% in Q3 2026, buying an estimated $7.29M and bringing the position to 425,042 shares worth $14.5M. The position accounts for 0.04% of the portfolio, ranked #336.

Lord, Abbett & Co first reported a position in ALMR in Q2 2026 and has held it in 2 quarters since. 64 funds tracked by Wall St. Rank hold ALMR as of Q3 2026.

  • Lord, Abbett & Co held 425,042 shares of Alamar Biosciences worth $14.5M as of Q3 2026.
  • Lord, Abbett & Co bought 247,490 Alamar Biosciences shares in Q3 2026, an estimated $7.29M.
  • Alamar Biosciences made up 0.04% of Lord, Abbett & Co's portfolio in Q3 2026, its #336 holding.
  • Lord, Abbett & Co first reported a position in Alamar Biosciences in Q2 2026 and has held it in 2 quarters since.
  • 64 funds tracked by Wall St. Rank held Alamar Biosciences as of Q3 2026.

Based on Lord, Abbett & Co's 13F filing for Q3 2026, filed 13 Nov 2026.